Osteopenia Recruiting Phase 1 Trials for Dexamethasone (DB01234)

Also known as: Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0015922 (Osteopenia)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02101944Wild-type Reovirus in Combination With Carfilzomib and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple MyelomaTreatment